benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral]
- RxCUI
- 1110820
- RxNorm name
- benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral]
- Term type
- SBD
- Status
- Active
- Updated
- 2026-06-06 07:14:20
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062011
- Active start
- 062011
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzocaine | 75 MG / 1 ML | benzocaine | benzocaine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Mucosal Spray | 346163 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzocaine | 1399 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| RXNAV_STR | Finafta Multi Oral 7.5 % Mucosal Spray | NAMES |
| RxNorm Name | benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] | NAMES |
| RxNorm Synonym | Finafta Multi Oral 7.5 % Mucosal Spray | NAMES |
| RxNorm Synonym | Finafta Multi Oral 75 MG/ML Mucosal Spray | NAMES |
| TTY | SBD | ATTRIBUTES |
| SPL_SET_ID | 28c5a993-fb5f-4091-af15-32ccae4b9a7d | CODES |
| SPL_SET_ID | cb027ab8-4175-4cc0-a73e-991dfb113df9 | CODES |
| RxCUI | 1110820 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 58593-782-02 | 58593-782 | Finafta Benzocaine | Efficient Laboratories Inc. | M022 |
| 65852-001-02 | 65852-001 | Finafta Benzocaine | Dextrum Laboratories Inc. | M022 |
Drugs@FDA Applications#
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 28c5a993-fb5f-4091-af15-32ccae4b9a7d | Finafta Multi Oral 7.5 % Mucosal Spray | PSN | 12 | 20241014 | |
| 28c5a993-fb5f-4091-af15-32ccae4b9a7d | benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] | SBD | 12 | 20241014 | |
| 28c5a993-fb5f-4091-af15-32ccae4b9a7d | Finafta Multi Oral 75 MG/ML Mucosal Spray | SY | 12 | 20241014 | |
| 28c5a993-fb5f-4091-af15-32ccae4b9a7d | Finafta Multi Oral 7.5 % Mucosal Spray | SY | 12 | 20241014 | |
| cb027ab8-4175-4cc0-a73e-991dfb113df9 | Finafta Multi Oral 7.5 % Mucosal Spray | PSN | 1 | Finafta Multioral | 20250923 |
| cb027ab8-4175-4cc0-a73e-991dfb113df9 | benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] | SBD | 1 | Finafta Multioral | 20250923 |
| cb027ab8-4175-4cc0-a73e-991dfb113df9 | Finafta Multi Oral 75 MG/ML Mucosal Spray | SY | 1 | Finafta Multioral | 20250923 |
| cb027ab8-4175-4cc0-a73e-991dfb113df9 | Finafta Multi Oral 7.5 % Mucosal Spray | SY | 1 | Finafta Multioral | 20250923 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| cb027ab8-4175-4cc0-a73e-991dfb113df9 | Finafta Multioral | Dextrum Laboratories Inc. | 20250923 |
| 28c5a993-fb5f-4091-af15-32ccae4b9a7d | Efficient Laboratories Inc. | 20241014 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | benzocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | benzocaine | |
| ATC | N01BA | Esters of aminobenzoic acid | ATC1-4 | benzocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | benzocaine | |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | benzocaine |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | benzocaine |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | benzocaine |
| MEDRT | D001566 | Benzocaine | CHEM | has_ingredient | benzocaine |
| MEDRT | D001424 | Bacterial Infections | DISEASE | ci_with | benzocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | benzocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzocaine |
| MEDRT | D004433 | Earache | DISEASE | may_treat | benzocaine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | benzocaine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | benzocaine |
| MEDRT | D006561 | Herpes Simplex | DISEASE | may_treat | benzocaine |
| MEDRT | D019226 | Oral Ulcer | DISEASE | may_treat | benzocaine |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | benzocaine |
| MEDRT | D010033 | Otitis Media | DISEASE | may_treat | benzocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | benzocaine |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | benzocaine |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | benzocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | benzocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | benzocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 75 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SBD |
| CODES | RxCUI | 1110820 |
| CODES | SPL_SET_ID | 28c5a993-fb5f-4091-af15-32ccae4b9a7d |
| CODES | SPL_SET_ID | cb027ab8-4175-4cc0-a73e-991dfb113df9 |
| NAMES | Prescribable Synonym | Finafta Multi Oral 7.5 % Mucosal Spray |
| NAMES | RXNAV_STR | Finafta Multi Oral 7.5 % Mucosal Spray |
| NAMES | RxNorm Name | benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] |
| NAMES | RxNorm Synonym | Finafta Multi Oral 7.5 % Mucosal Spray |
| NAMES | RxNorm Synonym | Finafta Multi Oral 75 MG/ML Mucosal Spray |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |